US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.308
  • +0.003+0.82%
Trading Nov 21 14:42 ET
16.87MMarket Cap-175P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-47.47%2.56M
-85.71%991K
-65.37%2.14M
-49.92%20.97M
-7.88%3M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
81.81%41.87M
297.20%3.26M
Operating revenue
-73.33%1.3M
--0
-75.47%1.51M
-51.59%20.27M
-29.32%2.31M
-55.00%4.87M
-69.86%6.93M
28.71%6.17M
81.81%41.87M
297.20%3.26M
Cost of revenue
0
0
-76.06%620K
-15.03%6.17M
-71.46%608K
-49.00%1.56M
1.42M
24.46%2.59M
7.27M
2.13M
Gross profit
-22.73%2.56M
-82.03%991K
-57.62%1.52M
-57.24%14.79M
111.85%2.4M
-57.36%3.31M
-76.02%5.52M
31.97%3.58M
50.26%34.6M
37.76%1.13M
Operating expense
-75.67%7.84M
-58.48%15.72M
-7.83%28.78M
11.59%136.29M
7.91%35M
1.91%32.21M
37.78%37.86M
1.98%31.23M
8.94%122.14M
-5.55%32.44M
Selling and administrative expenses
-4.79%6.4M
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
2.88%30.13M
-44.29%6.4M
-General and administrative expense
-4.79%6.4M
-15.24%6.37M
-1.11%6.79M
-8.23%27.65M
2.39%6.55M
-2.27%6.72M
-0.32%7.51M
-26.33%6.86M
2.88%30.13M
-44.29%6.4M
Research and development costs
-94.65%1.36M
-69.29%9.31M
-9.74%21.96M
18.10%108.51M
9.25%28.42M
3.08%25.45M
52.27%30.31M
14.39%24.33M
11.10%91.88M
13.92%26.01M
Depreciation amortization depletion
135.48%73K
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
2.40%128K
0.00%32K
-Depreciation and amortization
135.48%73K
25.81%39K
3.45%30K
1.56%130K
21.88%39K
-3.13%31K
-3.13%31K
-9.38%29K
2.40%128K
0.00%32K
Operating profit
81.73%-5.28M
54.47%-14.73M
1.39%-27.27M
-38.80%-121.5M
-4.15%-32.61M
-21.19%-28.9M
-623.17%-32.34M
0.94%-27.65M
1.74%-87.54M
6.61%-31.31M
Net non-operating interest income expense
-1.96M
-1.91M
-1.98M
-604K
-604K
0
0
0
0
Non-operating interest expense
--1.96M
--1.91M
--1.98M
--604K
--604K
--0
--0
--0
--0
----
Other net income (expense)
-704.50%-5.24M
-492.68%-3.38M
-247.11%-1.45M
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
221.03%2.06M
591.43%968K
Special income (charges)
---6M
---4.07M
---2.4M
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--707K
--2.58M
--2.4M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--4.27M
----
----
----
----
--0
----
----
----
----
-Write off
--1.02M
--1.49M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-11.55%766K
-19.98%689K
-3.35%952K
73.99%3.59M
-9.71%874K
30.23%866K
223.68%861K
508.02%985K
221.03%2.06M
591.43%968K
Income before tax
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Income tax
Net income
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Net income continuous Operations
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Minority interest income
Net income attributable to the parent company
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Basic earnings per share
55.77%-0.23
36.21%-0.37
-14.29%-0.56
-37.74%-2.19
-5.36%-0.59
-20.93%-0.52
-625.00%-0.58
5.77%-0.49
8.62%-1.59
11.11%-0.56
Diluted earnings per share
55.77%-0.23
36.21%-0.37
-14.29%-0.56
-37.74%-2.19
-5.36%-0.59
-20.93%-0.52
-625.00%-0.58
5.77%-0.49
8.62%-1.59
11.11%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -47.47%2.56M-85.71%991K-65.37%2.14M-49.92%20.97M-7.88%3M-55.00%4.87M-69.86%6.93M28.71%6.17M81.81%41.87M297.20%3.26M
Operating revenue -73.33%1.3M--0-75.47%1.51M-51.59%20.27M-29.32%2.31M-55.00%4.87M-69.86%6.93M28.71%6.17M81.81%41.87M297.20%3.26M
Cost of revenue 00-76.06%620K-15.03%6.17M-71.46%608K-49.00%1.56M1.42M24.46%2.59M7.27M2.13M
Gross profit -22.73%2.56M-82.03%991K-57.62%1.52M-57.24%14.79M111.85%2.4M-57.36%3.31M-76.02%5.52M31.97%3.58M50.26%34.6M37.76%1.13M
Operating expense -75.67%7.84M-58.48%15.72M-7.83%28.78M11.59%136.29M7.91%35M1.91%32.21M37.78%37.86M1.98%31.23M8.94%122.14M-5.55%32.44M
Selling and administrative expenses -4.79%6.4M-15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M2.88%30.13M-44.29%6.4M
-General and administrative expense -4.79%6.4M-15.24%6.37M-1.11%6.79M-8.23%27.65M2.39%6.55M-2.27%6.72M-0.32%7.51M-26.33%6.86M2.88%30.13M-44.29%6.4M
Research and development costs -94.65%1.36M-69.29%9.31M-9.74%21.96M18.10%108.51M9.25%28.42M3.08%25.45M52.27%30.31M14.39%24.33M11.10%91.88M13.92%26.01M
Depreciation amortization depletion 135.48%73K25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K2.40%128K0.00%32K
-Depreciation and amortization 135.48%73K25.81%39K3.45%30K1.56%130K21.88%39K-3.13%31K-3.13%31K-9.38%29K2.40%128K0.00%32K
Operating profit 81.73%-5.28M54.47%-14.73M1.39%-27.27M-38.80%-121.5M-4.15%-32.61M-21.19%-28.9M-623.17%-32.34M0.94%-27.65M1.74%-87.54M6.61%-31.31M
Net non-operating interest income expense -1.96M-1.91M-1.98M-604K-604K0000
Non-operating interest expense --1.96M--1.91M--1.98M--604K--604K--0--0--0--0----
Other net income (expense) -704.50%-5.24M-492.68%-3.38M-247.11%-1.45M73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K221.03%2.06M591.43%968K
Special income (charges) ---6M---4.07M---2.4M----------0--0--0--------
-Less：Restructuring and merger&acquisition --707K--2.58M--2.4M----------0--0--0--------
-Less:Impairment of capital assets --4.27M------------------0----------------
-Write off --1.02M--1.49M--------------0--0------------
Other non- operating income (expenses) -11.55%766K-19.98%689K-3.35%952K73.99%3.59M-9.71%874K30.23%866K223.68%861K508.02%985K221.03%2.06M591.43%968K
Income before tax 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Income tax
Net income 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Net income continuous Operations 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Minority interest income
Net income attributable to the parent company 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Basic earnings per share 55.77%-0.2336.21%-0.37-14.29%-0.56-37.74%-2.19-5.36%-0.59-20.93%-0.52-625.00%-0.585.77%-0.498.62%-1.5911.11%-0.56
Diluted earnings per share 55.77%-0.2336.21%-0.37-14.29%-0.56-37.74%-2.19-5.36%-0.59-20.93%-0.52-625.00%-0.585.77%-0.498.62%-1.5911.11%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data